Institute Fires Off Suit Against Amgen Over Royalties
A cancer research center has launched a suit against biotech giant Amgen Inc. for allegedly skimping on more than $72 million in royalty payments on two drugs for preventing infections....To view the full article, register now.
Already a subscriber? Click here to view full article